Specific pro-inflammatory cytokine such as IL-8 and IL-1β blockade therapies are currently emerging and have demonstrated as a certain degree of efficacy in COPD [30,31,32]. This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.